Column Group LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001833486 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 17, 2021

Total Value: $1.044B (100.0% shares, 0.0% debt)

Holdings (6)

— NGM Biopharmaceuticals Inc 42.9%

Value $448M Shares 15,396,116 Est. Cost $30.30 Unrealized —

NRIX Nurix Therapeutics Inc 16.0%

Value $167M Shares 5,383,333 Est. Cost $33.14 Unrealized +14.2%

RVMD Revolution Medicines Inc 15.7%

Value $164M Shares 3,580,252 Est. Cost $39.54 Unrealized +13.4%

ORIC ORIC Pharmaceuticals Inc. 11.2%

Value $117M Shares 4,768,181 Est. Cost $28.69 Unrealized +10.1%

— RAPT Therapeutics Inc 8.3%

Value $86.26M Shares 3,885,679 Est. Cost $19.75 Unrealized —

— Constellation Pharmaceuticals Inc. 5.9%

Value $61.44M Shares 2,626,631 Est. Cost $28.80 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	NGM Biopharmaceuticals Inc	15,396,116	$448M	42.9%	$30.30	—	COM	62921N105
NRIX	Nurix Therapeutics Inc	5,383,333	$167M	16.0%	$33.14	+14.2%	COM	67080M103
RVMD	Revolution Medicines Inc	3,580,252	$164M	15.7%	$39.54	+13.4%	COM	76155X100
ORIC	ORIC Pharmaceuticals Inc.	4,768,181	$117M	11.2%	$28.69	+10.1%	COM	68622P109
—	RAPT Therapeutics Inc	3,885,679	$86.26M	8.3%	$19.75	—	COM	75382E109
—	Constellation Pharmaceuticals Inc.	2,626,631	$61.44M	5.9%	$28.80	—	COM	210373106